Change in FVC ≤2% predicted at week 6 (n=389) | Change in UCSD-SOBQ score of <5 points at week 6 (n=351) | Change in FVC ≤2% predicted at week 52 (n=187) | Change in FVC ≤5% predicted at week 52 (n=419) | Change in UCSD-SOBQ score of <5 points at week 52 (n=194) | No change on PGI-C at week 52 (n=316) | |||||||
ICC | Effect size | ICC | Effect size | ICC | Effect size | ICC | Effect size | ICC | Effect size | ICC | Effect size | |
SGRQ | ||||||||||||
Total* | 0.83 (0.80–0.86) | −0.029 | 0.91 (0.88–0.92) | −0.047 | 0.75 (0.68–0.81) | 0.080 | 0.72 (0.67–0.77) | 0.047 | 0.87 (0.83–0.90) | −0.003 | 0.76 (0.71–0.80) | 0.181 |
Activity domain | 0.81 (0.77–0.84) | 0.030 | 0.88 (0.85–0.90) | −0.014 | 0.75 (0.68–0.81) | 0.077 | 0.71 (0.66–0.76) | 0.074 | 0.87 (0.83–0.90) | 0.048 | 0.73 (0.68–0.78) | 0.220 |
Impact domain | 0.76 (0.72–0.80) | −0.035 | 0.87 (0.84–0.89) | −0.078 | 0.67 (0.59–0.75) | 0.088 | 0.65 (0.58–0.70) | 0.068 | 0.80 (0.75–0.85) | −0.011 | 0.68 (0.62–0.74) | 0.166 |
Symptoms domain | 0.72 (0.67–0.77) | −0.060 | 0.76 (0.71–0.80) | 0.015 | 0.72 (0.64–0.78) | 0.033 | 0.66 (0.60–0.71) | −0.071 | 0.68 (0.60–0.75) | −0.038 | 0.66 (0.59–0.72) | 0.067 |
UCSD-SOBQ score† | 0.83 (0.80–0.86) | 0.044 | N/A | N/A | 0.75 (0.68–0.81) | 0.166 | 0.72 (0.66–0.76) | 0.167 | N/A | N/A | 0.75 (0.70–0.80) | 0.235 |
CASA-Q | ||||||||||||
Cough impacts domain | 0.74 (0.70–0.79) | 0.097 | 0.84 (0.81–0.87) | 0.043 | 0.67 (0.58–0.74) | 0.002 | 0.69 (0.63–0.74) | 0.016 | 0.76 (0.70–0.82) | 0.023 | 0.70 (0.64–0.75) | −0.099 |
Cough symptoms domain | 0.70 (0.65–0.75) | 0.055 | 0.75 (0.70–0.79) | 0.058 | 0.60 (0.50–0.69) | −0.015 | 0.61 (0.54–0.67) | 0.052 | 0.71 (0.64–0.77) | 0.077 | 0.66 (0.59–0.72) | −0.028 |
EQ-5D VAS | N/C | N/C | N/C | N/C | 0.60 (0.50–0.68) | −0.030 | 0.49 (0.42–0.56) | −0.074 | 0.68 (0.60–0.75) | −0.124 | 0.51 (0.42–0.58) | −0.204 |
*n=315 patients with no change on PGI-C.
† n=410 for patients with FVC ≤5% predicted group and n=309 for patients with no change on PGI-C.
N/C: EQ-5D VAS data were not collected at week 6.
CASA-Q, Cough and Sputum Assessment Questionnaire; EQ-5D VAS, EuroQol 5-Dimensional Quality of Life Questionnaire Visual Analogue Scale; FVC, forced vital capacity; ICC, intraclass correlation coefficient; PGI-C, Patient ’s Global Impression of Change; SGRQ, St George’s Respiratory Questionnaire; UCSD-SOBQ, University of California San Diego Shortness of Breath Questionnaire.